Skip to main content

Table 4 Polymorphisms at known drug resistance positions of HIV-1 subtype B among chronically infected patients from Northwest Ethiopia (N = 160)

From: Clade homogeneity and Pol gene polymorphisms in chronically HIV-1 infected antiretroviral treatment naive patients after the roll out of ART in Ethiopia

Drug class Polymorphisms Number of cases Frequency (%)
NRTI   16 10.0
  M41R/N 2/1 1.9
  D67E/G/K 1/1/1 1.9
  Q151P/Q/R 1/1 1.3
  M184L/M 4 2.5
  T215A/P/T 3/1 2.5
NNRTI   52 33.5
  A98S/Q 38/1 24.4
  L100V 1 0.6
  K101R/X 3/1 2.5
  K103E/R 2 1.3
  V108T 1 0.6
  E138Y/D 1/1 1.3
  G190 D/R 1/1 1.3
PR   11 6.9
  V32A/V 1 0.6
  L10I 3 1.9
  L10V 2 1.3
  L10L/R 1 0.6
  V11I/V 1 0.6
  V11F/V 1 0.6
  V11G/V 1 0.6
  F53L 1 0.6
  1. Keys: Numbers correspond to amino acid positions. The first letter corresponds to the wild-type amino acid; the substituted amino acid is coded by the last letter.